New Lawsuit Filed by Actos Bladder Cancer Victim
By Andrea Gressman
Actos is Takeda Pharmaceutical’s popular diabetes drug, but despite its popularity it has been the subject of numerous lawsuits alleging an increased side effect risk of contracting bladder cancer with the use of the drug. On November 6th, 2012 a Georgia man filed his own Actos lawsuit, joining the many Actos bladder cancer lawsuits already filed against Takeda. Filed in the Circuit Court of Cook County, Illinois, the Actos lawsuit alleges that the plaintiff was diagnosed with bladder cancer due to taking the medication.
The plaintiff is Kevin C. Ogle of Georgia. His Actos lawsuit claims that he took the Takeda drug for five years and subsequently developed bladder cancer, brought on by Actos. Mr. Ogle began taking Actos in July of 2004 to treat his Type II diabetes. He consistently used the drug for nearly 5 years, ceasing use in June of 2009. Less than a year after he stopped taking the drug, his medical problems began.
Mr. Ogle underwent a CT scan on April 22, 2010 and a cystoscopy on April 26, 2010. He was diagnosed with bladder cancer as a result of these tests on May 13th of 2011. The Actos injury lawsuit alleges that the diagnosis has forced him to undergo several extremely invasive tests and treatments. As a part of the treatment of bladder cancer, the patient needed a transurethral resection of the tumor in the bladder, a bilateral retrograde pyelogram, a left urethral stent placement, clot evacuation, and a set of treatments known as Bacillus Calmette-Guerin treatments.
These treatments were most recently administered in March of 2012 but will likely need to continue in the future. Like many other Actos bladder cancer lawsuits filed against Takeda, the plaintiff alleges that Takeda failed to properly warn him of the dangers of Actos. Mr. Ogle was unaware of the side effect risks associated with prolonged Actos use until the FDA released a warning on June 16, 2011 — this date is one month after he had been diagnosed with bladder cancer.
He states that this failure to warn exposed him to unnecessary danger and he would have opted for alternative drugs had he been aware of the dangers. As a result, his Actos lawsuit cites failure to warn, defective design, negligence and negligent misrepresentation. Mr. Ogle’s wife has also joined the Actos lawsuit by bringing a count of loss of consortium against Takeda. The Actos lawsuit seeks damages of at least $50,000 as a relief for his sufferings.
This is a new Actos injury lawsuit in a large swarm of litigation about Actos. The FDA has received over 1,000 complaints of drug induced bladder cancer. France and Germany have both banned the sale of Actos due to the dangers of bladder cancer.
If you or someone you love has been diagnosed with bladder cancer or bladder tumors and believe that Actos is the cause of such side effects, visit the Actos Bladder Cancer Class Action Lawsuit Investigation page to learn more about your legal options. An Actos lawsuit attorney will provide you with a free consultation and help you through the legal process.
Updated December 7th, 2012
All medical device, dangerous drug and medical class action and lawsuit news updates are listed in the Drug and Medical Device section of Top Class Actions.
Top Class Actions Legal Statement
